ITMCTR1900002839Not yet recruitingPhase 4
Effects of Danlou Tablet for the treatment of stable angina pectoris: a study protocol of a randomized, double-blind, and placebo-controlled clinical trial
Guang'anmen Hospital,Chinese Academy of Traditiona Chinese medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 30 to 75 (—)
- Sex
- All
Inclusion Criteria
- •1. Conform to the diagnosis of coronary heart disease stable angina pectoris with intermingled phlegm and blood stasis Pattern;
- •2. Between the ages of 30 and 75 years;
- •3. Volunteer for this event and sign an informed consent form.
Exclusion Criteria
- •1. Unstable angina pectoris and acute myocardial infarction; other congenital heart disease, valvular disease, severe neurosis caused by chest pain; heart function of grade III or IV; chest pain caused by arrhythmia;
- •2. Acute stage of cerebral infarction;
- •3. Complicated with heart, brain, liver, kidney, hematopoietic system and other serious primary diseases abnormal renal function;
- •4. Acute infection within the last two weeks;
- •5. Patients with other serious diseases that require treatment;
- •6. Mental disorders or mental retardation that cannot complete the questionnaire;
- •7. Pregnant and lactating women;
- •8. Tendency to bleed, abnormal of DIC or INR, low platelet;
- •9. Patients who did not participate in other clinical trials within 1 month;
- •10. Allergic constitution or allergic to test drug ingredient.
Investigators
Similar Trials
Not yet recruiting
Phase 1
Effect of Danlou Tablets with good compliance to medical advice on the risk of short-term adverse cardiovascular events after PCI in patients with coronary heart diseaseCoronary heart diseaseITMCTR2024000221Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Unknown
Phase 4
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to RevascularizationCoronary Artery Disease(CAD)NCT03072082Jun Li440
Not yet recruiting
Phase 4
Study for the effect of Danlou tablet on gut microbiota of CHD patients and its metabolomicsITMCTR1900002563Traditional Chinese Medicine Hospital of Tailai County, Qiqihar City, Heilongjiang Province
Recruiting
Phase 4
Clinical study of Dan Zhi Xiaoyao Tablets in the treatment of burning mouth syndrome: a randomized controlled trialBurning Mouth SyndromeITMCTR2000004110The Ninth People's Hospital affiliated to Shanghai Jiaotong University Medical College
Not yet recruiting
Unknown
A clinical study to evaluate the effect of dantrolene sodium hydrate on kidney function and albuminuria in patients with CKDJPRN-jRCTs061230094chinoumi Hitoshi15